Voice-activated and Touchscreen-controlled Smart Speaker Intervention for Older Adults With Poorly Controlled Type 2 Diabetes
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: VATC-SS Intervention.
- Who it may be relevant to
- Registry conditions: Diabetes, Diabetes (DM), Type 2 Diabetes. Basic parameters: from 50 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This is a pre-post pilot study that will test the feasibility and acceptability of a health educator delivered diabetes education and skills training intervention using a voice-activated, touch screen controlled, smart speaker. We will enroll 30 adults aged 50 and older with poorly controlled type 2 diabetes as defined by a hemoglobin A1C of 8% in the study.
Interventions
- Behavioral VATC-SS Intervention
Individuals in the VATC-SS intervention will receive weekly diabetes education and skills training calls for 12 weeks from a health educator through the voice-activated, touch screen controlled smart speaker.
Primary outcome measures
- HemoglobinA1C [Time frame: Baseline and 3-months post enrollment]
- Blood Pressure [Time frame: Baseline and 3-months post-enrollment]
- Low-Density Lipoprotein Cholesterol [Time frame: Baseline and 3-months post-enrollment]
Secondary outcome measures (3)
- Depression [Time frame: Baseline and 3-months post-enrollment]
- Social Isolation [Time frame: Baseline and 3-months post-enrollment]
- Loneliness [Time frame: Baseline and 3-months post-enrollment]
Eligibility criteria
Inclusion criteria
- 1\) Aged 50 and older; 2) clinical diagnosis of poorly controlled type 2 diabetes, defined as HbA1C greater than or equal to 8% at the screening visit; 3) willing to install and use the VATC-SS for the 3 months of the study.
Exclusion criteria
- 1\) Mental confusion at screening assessment suggesting significant dementia; 2) alcohol or drug abuse/dependency at screening assessment; 3) active psychosis or acute mental disorder at screening assessment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Health services research
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07734259 · PRO00058852